These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 10861026)

  • 41. Short-term immunosuppression facilitates induction of mixed chimerism and tolerance after bone marrow transplantation without cytoreductive conditioning.
    Blaha P; Bigenzahn S; Koporc Z; Sykes M; Muehlbacher F; Wekerle T
    Transplantation; 2005 Jul; 80(2):237-43. PubMed ID: 16041269
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The requirement for allogeneic chimerism for second transfer of tolerance from mixed allogeneic chimeras (A+B-->A) to secondary recipients.
    Wren SM; Hronakes ML; Ildstad ST
    Transplantation; 1992 Dec; 54(6):1031-40. PubMed ID: 1465769
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanisms involved in the establishment of tolerance through costimulatory blockade and BMT: lack of requirement for CD40L-mediated signaling for tolerance or deletion of donor-reactive CD4+ cells.
    Kurtz J; Ito H; Wekerle T; Shaffer J; Sykes M
    Am J Transplant; 2001 Nov; 1(4):339-49. PubMed ID: 12099378
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment.
    Wekerle T; Kurtz J; Ito H; Ronquillo JV; Dong V; Zhao G; Shaffer J; Sayegh MH; Sykes M
    Nat Med; 2000 Apr; 6(4):464-9. PubMed ID: 10742157
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
    Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
    Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapamycin and CTLA4Ig synergize to induce stable mixed chimerism without the need for CD40 blockade.
    Pilat N; Klaus C; Schwarz C; Hock K; Oberhuber R; Schwaiger E; Gattringer M; Ramsey H; Baranyi U; Zelger B; Brandacher G; Wrba F; Wekerle T
    Am J Transplant; 2015 Jun; 15(6):1568-79. PubMed ID: 25783859
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Skin allograft maintenance in a new synchimeric model system of tolerance.
    Iwakoshi NN; Markees TG; Turgeon N; Thornley T; Cuthbert A; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2001 Dec; 167(11):6623-30. PubMed ID: 11714833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pre-treatment of allogeneic bone marrow recipients with the CXCR4 antagonist AMD3100 transiently enhances hematopoietic chimerism without promoting donor-specific skin allograft tolerance.
    Li Z; Xu X; Weiss ID; Jacobson O; Murphy PM
    Transpl Immunol; 2015 Oct; 33(2):125-9. PubMed ID: 26209354
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus.
    Morelli AE; Antonysamy MA; Takayama T; Hackstein H; Chen Z; Qian S; Zurowski NB; Thomson AW
    J Immunol; 2000 Jul; 165(1):226-37. PubMed ID: 10861056
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
    Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H
    Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions.
    Taylor PA; Lees CJ; Wilson JM; Ehrhardt MJ; Campbell MT; Noelle RJ; Blazar BR
    Blood; 2002 Nov; 100(9):3400-7. PubMed ID: 12384443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combined host-conditioning with CTLA4-Ig, tacrolimus, anti-lymphocyte serum, and low-dose radiation leads to stable mixed hematopoietic chimerism.
    Li S; Thanikachalam M; Pang M; Carreno M; Aitouche A; Pham SM
    Exp Hematol; 2001 Apr; 29(4):534-41. PubMed ID: 11301194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without graft-versus-host disease in rat.
    Zhu ZX; Fan LY; Wang Q
    Eur Surg Res; 2011; 46(3):109-17. PubMed ID: 21242693
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methyl-Guanine-Methyl-Transferase Transgenic Bone Marrow Transplantation Allows N,N-bis(2-chloroethyl)-Nitrosourea Driven Donor Mixed-Chimerism Without Graft-Versus-Host Disease, and With Donor-Specific Allograft Tolerance.
    Hu M; Kramer B; Zhang GY; Wang YM; Watson D; Howden B; McCowage G; Alexander IE; Gunning P; Alexander SI
    Transplantation; 2015 Dec; 99(12):2476-84. PubMed ID: 26177088
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prenatal tolerance induction: relationship between cell dose, marrow T-cells, chimerism, and tolerance.
    Chen JC; Chang ML; Huang SF; Chang PY; Muench MO; Fu RH; Ou LS; Kuo ML
    Cell Transplant; 2008; 17(5):495-506. PubMed ID: 18714669
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Towards a myeloablative regimen with clinical potential: I. Treosulfan conditioning and bone marrow transplantation allow induction of donor-specific tolerance for skin grafts across full MHC barriers.
    van Pel M; van Breugel DW; Vos W; Ploemacher RE; Boog CJ
    Bone Marrow Transplant; 2003 Jul; 32(1):15-22. PubMed ID: 12815473
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.
    Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
    J Surg Res; 2012 Dec; 178(2):974-81. PubMed ID: 22819314
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of tolerance induction through prenatal marrow transplantation: the requirement for a threshold level of chimerism to establish rather than maintain postnatal skin tolerance.
    Chen JC; Kuo ML; Ou LS; Chang PY; Muench MO; Shen CR; Chang HL; Yu HY; Fu RH
    Cell Transplant; 2010; 19(12):1609-22. PubMed ID: 20719075
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1,3Gal-mediated graft rejection.
    Ohdan H; Yang YG; Shimizu A; Swenson KG; Sykes M
    J Clin Invest; 1999 Aug; 104(3):281-90. PubMed ID: 10430609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elimination of porcine hemopoietic cells by macrophages in mice.
    Abe M; Cheng J; Qi J; Glaser RM; Thall AD; Sykes M; Yang YG
    J Immunol; 2002 Jan; 168(2):621-8. PubMed ID: 11777954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.